MountBM. Morphine drips, terminal sedation, and slow euthanasia: definitions and facts, not anecdotes. J Palliat Care1996; 12(4): 31–37.
7.
PortenoyRK. Morphine infusions at the end of life: the pitfalls in reasoning from anecdote. J Palliat Care1996; 12(4): 44–46.
8.
StoneP, PhillipsC, SpruitO, WaightC.A comparison of the use of sedatives in a hospital support team and in hospice. Palliat Med1997; 11: 140–144.
9.
VentafriddaV, RipamontiC, deConnoF, Symptom prevalence and control during cancer patients last days of life. J Palliat Care1990; 6(3): 7–11.
10.
BurkeAL, DiamondPL, HulbertJ, YeatmanJ, FarrEA. Terminal restlessness — its management and the role of midazolam. Med J Austr1991; 155: 485–487.
11.
MoritaT, InoueS, ChiharaS.Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Sympt Manag1996; 12: 32–38.
12.
FainsingerRL, TapperM, BrueraE.A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care1993; 9(3): 4–8.
13.
GramLF. Fluoxetine. N Engl J Med1994; 20: 1354–1361.
14.
PreskornSH, BeberJH, FaulJC, HirschfeldRM. Serious adverse effects of combining fluoxetine and tricyclic antidepressants. Am J Psychiatr1990; 147: 532.
15.
NemeroffCB, DeVaneCL, PollockBG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatr1996; 153: 311–320.
16.
Compendium of Pharmaceuticals and Specialties, 32nd Edition.Ottawa: Canadian Pharmaceutical Association, 1997; pp. 1266–1267.
17.
de StoutzND, TapperM, FainsingerRL. Reversible delirium in terminally ill patients. J Pain Sympt Manag1995; 10: 249–253.
18.
FainsingerR, BrueraE.Case report: is this opioid analgesic tolerance?J Pain Sympt Manag1995; 10(7): 573–577.
19.
FainsingerRL, MillerMJ, BrueraE.Morphine intoxication during acute reversible renal insufficiency (Letter to the Editor). J Palliat Care1992; 8(2): 52–53.
20.
FainsingerRL, SchoellerT, BoiskinM, BrueraE.Palliative care round: cognitive failure and coma after renal failure in a patient receiving captopril and hydromorphone. J Palliat Care1993; 9(1): 53–55.
21.
BrueraE, FrancoJJ, MaltoniM, WatanabeS, Suraez-AlmazorM.Changing pattern of agitated impaired mental status in patients with advanced cancer: association of cognitive monitoring, hydration, and opioid rotation. J Pain Sympt Manag1995; 10: 287–291.
22.
PereiraJ, HansonJ, BrueraE.The frequency and clinical cause of cognitive impairment in patients with terminal cancer. Cancer1997; 79: 835–842.
